Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

The Drugs Control Administration, Telangana, has found gyms and fitness centres illegally selling steroids and stimulants ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

The drug’s effects on cardiovascular and inflammation markers outshined its failure to spur weight loss, analysts wrote.

A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

The findings suggest weight loss drugs independently affect heart health risks, researchers said. View on euronews ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older ...